Communication Services

Cinemark Holdings, Inc. (CNK)

$3.3B
Market Cap
27.0
P/E Ratio
1.13
Beta
1.28%
Dividend Yield
Piotroski 4/9Altman Z 1.3 DistressBeneish M -2.61 CleanROIC−WACC -1.9%

Quantitative Summary

Deterministic

CNK trades at 27.0x earnings, roughly in line with its sector average of 32.1x. Financial health is average: Piotroski 4/9, Altman Z 1.3.

Generated deterministically from quant metrics and financial statements. Not a recommendation.

Algorithmic Teardown

AI-Generated

The fundamental economics of Cinemark Holdings reveal a capital allocation challenge, evidenced by an ROIC-WACC spread of -1.9%, indicating the firm is currently generating returns below its cost of equity. This underperformance persists despite robust operational leverage in pricing power, as reflected by a healthy 64.1% gross margin; however, these margins are compressed into a narrow net income stream yielding only a 4.4% net margin and sluggish revenue growth of 2.1%. The DuPont decomposition suggests that while top-line efficiency remains intact via high gross spreads, the bottom line suffers from either elevated operating costs or significant leverage drag, though the Altman Z-Score of 1.3 signals potential distress risks rather than insolvency. Creditworthiness appears fragile given this low Z-score, yet financial statement integrity seems preserved with a strong Beneish M-Score of -2.61 and a moderate Piotroski F-Score of 4/9, suggesting earnings quality is not being manipulated despite the weak growth trajectory.

Valuation metrics present a mixed picture where the current P/E multiple of 27.0x trades at a discount to the sector average of 37.7x, potentially reflecting market skepticism regarding its capital efficiency and growth ceiling rather than pure undervaluation. A DCF analysis implies a fair value of $40, yet this target must be weighed against the structural headwinds highlighted by the negative spread between return on invested capital and the weighted average cost of capital. The market appears to be pricing in limited upside given the tepid revenue expansion, while the current multiple may offer some buffer if management can eventually turn the ROIC-WACC dynamic positive through improved asset utilization or margin expansion.

The risk/reward profile is skewed by conflicting signals: the low Altman Z-Score introduces solvency concerns that contrast with a clean Beneish M-Score and moderate Piotroski score, creating uncertainty about future cash flow stability versus accounting reliability. Investors must weigh whether the current valuation discount adequately compensates for the capital destruction evident in the negative ROIC spread or if it represents an opportunity to buy into a turnaround story pending operational improvements.

Generated by LLM from quantitative data inputs. May contain inaccuracies. Not investment advice.

DCF Sandbox

Interactive

Sensitivity Matrix

TG ↓ / WACC →6.9%8.9%10.9%
2%$53$34$23
3%$67$40$26
4%$91$48$31

Center = base case. Green = >10% upside, Red = >10% downside vs .

Pre-computed DCF: WACC=8.9%, terminal growth 3%. Fair value $40 (+0.0%). Not investment advice.

Valuation Context

27.0x
CNK P/E
32.1x
Sector Avg
-16%
vs Sector

Price Chart with Moving Averages

Loading chart...
SMA 50 SMA 200

Quant Health Deep Dive

4/9
Piotroski F-Score
Average — mixed operational signals
1.3
Altman Z-Score
Distress Zone — below 1.8 threshold per academic model. Thresholds: >3 safe, 1.8–3 grey, <1.8 distress.
-2.61
Beneish M-Score
Below threshold — no statistical earnings quality concern per Beneish model. Threshold: <-2.22 = below threshold.

Profitability & Value Creation

64.1%
Gross Margin
4.4%
Net Margin
7.0%
ROIC
8.9%
WACC
ROIC − WACC Spread: -1.9%— Negative spread.
+2.1%
Revenue Growth (YoY)
-55.4%
Earnings Growth (YoY)
177.2M
Free Cash Flow
22%
FCF Payout Ratio

✅ Conservative payout — room for dividend increases.

Balance Sheet Health

9.72x
Debt / Equity
0.71x
Current Ratio
1.9x
Interest Coverage
2.9x
Net Debt / EBITDA
3.67%
FCF Yield
519.4M
EBITDA

Earnings Surprise History

Q4
✗ Miss
Est: $-0.30
Act: $-0.32
-7.6%
Q3
✗ Miss
Est: $0.75
Act: $0.63
-16.4%
Q2
✗ Miss
Est: $0.45
Act: $0.40
-12.0%
Q1
✓ Beat
Est: $0.28
Act: $0.29
+2.0%

EPS estimates vs actuals for the most recent reported quarters. Source: yfinance.

Underwater (Drawdown from Peak)

How far below the all-time high the price has been over time. Deeper = more pain for holders.

Loading drawdown chart...

Rolling 60-Day Beta vs S&P 500 (VOO)

How the stock's sensitivity to market moves changes over time. β > 1 = more volatile than the market.

Loading beta chart...
Rolling Beta Market (β = 1.0)

Fundamentals

11.9
Forward P/E
PEG Ratio
7.92
Price/Book
3M
Avg Volume
$34.01
52W High
$21.60
52W Low
52W Range Position

Passive Flow Attribution

ETF Draft Effect
$77M
Tracked Passive Exposure
7
ETFs Holding CNK
0.08%
Avg Weight in ETFs
$94B
Total ETF AUM

When investors buy or sell ETFs like SLYG or VOX, the fund manager is mechanically forced to buy or sell CNK shares regardless of Cinemark Holdings, Inc.'s individual fundamentals. We estimate $77M of passive capital is structurally linked to CNK through 7 tracked ETFs. Passive flows have a limited but growing influence on CNK's daily trading dynamics.

Passive exposure = Σ (ETF AUM × stock weight in ETF) across 7 tracked ETFs. Actual passive ownership is larger (includes mutual funds). Not investment advice.

ETF Contagion Visualizer

Simulate a price drop in Cinemark Holdings, Inc. to visualize passive redemption contagion across ETFs and collateral stocks.

CNK Shock
-0%
Est. Passive Redemption
$0
Systemic Risk
STABLE
CNKEpicenterVBKETFVTWOETFSPSMETFMETALow RiskGOOGLLow RiskGOOGLow RiskNFLXLow RiskVZHigh Risk
CNK Price Drop (%)0

If Cinemark Holdings, Inc. (CNK) experiences a significant drawdown, ETF redemptions can create collateral selling pressure on co-held stocks. Our model identifies Facebook Inc. Class A (META) as the most exposed collateral stock, sharing 1 ETFs with CNK. This is the "Passive Contagion" effect described in the Inelastic Market Hypothesis.

Contagion model based on shared ETF exposure and constituent weights across 7 tracked ETFs. Estimated selling pressure is a simplified model — actual impact depends on market liquidity, ETF redemption mechanics, and market-maker activity.

CNK Ownership Dynamics

Ticker
CNK

Float lock-up computed from 7 ETFs tracked by SecuritiesDB. Actual passive ownership is higher (includes mutual funds, pension funds, etc.).

CNK Capital Efficiency

How efficiently does Cinemark Holdings, Inc. convert operating profits into free cash? The FCF Conversion ratio measures the gap between accounting earnings and real cash generation.

Free Cash Flow
$177M
EBITDA
$519M
FCF Conversion
34%
Reinvestment Rate
66%
34% of EBITDA → Free Cash
0% (cash burn)25% (low)50% (efficient)100% (pure cash)
ROIC
7.0%
ROIC − WACC Spread
-1.9%

Cinemark Holdings, Inc. converts 34% of its EBITDA into free cash flow, a moderate conversion rate — significant EBITDA is consumed by capital expenditures, working capital changes, or interest payments. The 66% reinvestment rate signals aggressive capacity expansion. However, the ROIC-WACC spread is negative (-1.9%), suggesting reinvested capital is destroying shareholder value.

Capital efficiency = Free Cash Flow ÷ EBITDA. Reinvestment = (EBITDA − FCF) ÷ EBITDA. Metrics from latest annual filings. Not investment advice.

Fails-to-Deliver (FTD) History

SEC-reported settlement failures. Elevated FTDs can indicate high short-selling pressure, operational settlement issues, or naked shorting activity.

DateFailed SharesClose PriceNotional Value
2026-05-1318,584$26.28$488,387.52
2026-05-0714$27.73$388.22
2026-05-053,689$27.26$100,562.14
2026-04-3033$29.01$957.33
2026-04-201,872$30.01$56,178.72
2026-04-1438$30.37$1,154.06
2026-03-11100$26.66$2,666
2026-03-1033$27.07$893.31
2026-03-032,397$28.55$68,434.35
2026-02-25163$25.66$4,182.58
2026-02-2025,614$26.36$675,185.04
2026-02-1925,635$26.41$677,020.35
2026-02-11138$25.75$3,553.5
2026-02-0955$25.77$1,417.35
2026-02-031,471$24.67$36,289.57
2026-01-231,211$24.12$29,209.32
2026-01-2134,849$24.55$855,542.95
2026-01-20301,124$23.93$7.2M
2026-01-1212$22.47$269.64
2026-01-05688$23.53$16,188.64
2026-01-02984$23.24$22,868.16
2025-12-29670$22.86$15,316.2
2025-12-232,497$22.45$56,057.65
2025-12-2292,763$22.27$2.1M
2025-12-175$23.81$119.05
2025-12-155$24.65$123.25
2025-12-104,484$24.52$109,947.68
2025-11-26791,532$27.99$22.2M
2025-11-20382$30.10$11,498.2
2025-11-183,059$29.59$90,515.81

Source: SEC Regulation SHO FTD data. Data is reported with a ~30 day delay. High FTD quantities relative to average daily volume may indicate settlement stress.

Compare CNK to Peers

Quant metrics computed deterministically from financial statements and price data. Updated: N/A.

SecuritiesDB provides programmatic data aggregation for informational purposes only. None of the metrics, summaries, or algorithmic flags constitute a recommendation to buy or sell any security.